Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;20(5):314.
doi: 10.1038/s41574-024-00976-y.

Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern

Sunita M C De Sousa  1 , Alistair K Jukes  2 , Nicholas G Candy  2 , Ian M Chapman  3 , David J Torpy  3 , Brindha Shivalingam  4 , Peter-John Wormald  5 , Stephen Santoreneos  2
Affiliations

Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern

Sunita M C De Sousa et al. Nat Rev Endocrinol. 2024 May.
No abstract available

PubMed Disclaimer

References

    1. Petersenn, S. et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat. Rev. Endocrinol. 19, 722–740 (2023). - DOI - PubMed
    1. De Sousa, S. M. C. et al. Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors. J. Clin. Endocrinol. Metab. 105, dgz076 (2020). - DOI - PubMed
    1. De Sousa, S. M. C. Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? Endocr. Oncol. 2, R31–R50 (2022). - DOI - PubMed - PMC
    1. Gillam, M. P., Molitch, M. E., Lombardi, G. & Colao, A. Advances in the treatment of prolactinomas. Endocr. Rev. 27, 485–534 (2006). - DOI - PubMed
    1. Landolt, A. M., Keller, P. J., Froesch, E. R. & Mueller, J. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas? Lancet 2, 657–658 (1982). - DOI - PubMed

LinkOut - more resources